 | Neoleukin Therapeutics (NASDAQ:NLTX) Shares Gap Down to $11.97
americanbankingnews.com - April 12 at 11:30 AM |
| Neoleukin Therapeutics' (NLTX) "Buy" Rating Reiterated at Mizuho
americanbankingnews.com - April 12 at 12:46 AM |
| Carl Walkey Sells 1,800 Shares of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Stock
americanbankingnews.com - April 8 at 7:50 PM |
| Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Expected to Post Earnings of -$0.24 Per Share
americanbankingnews.com - April 6 at 10:18 PM |
| Neoleukin Therapeutics (NASDAQ:NLTX) Trading Down 4.3%
americanbankingnews.com - April 6 at 1:02 PM |
| Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) SVP Sells $21,528.00 in Stock
americanbankingnews.com - April 2 at 7:52 PM |
| Head-To-Head Comparison: Neoleukin Therapeutics (NASDAQ:NLTX) and Milestone Pharmaceuticals (NASDAQ:MIST)
americanbankingnews.com - March 31 at 8:44 AM |
| Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) to Post Q1 2022 Earnings of ($0.35) Per Share, Piper Sandler Forecasts
americanbankingnews.com - March 31 at 3:12 AM |
| Research Analysts Set Expectations for Neoleukin Therapeutics, Inc.'s Q1 2022 Earnings (NASDAQ:NLTX)
americanbankingnews.com - March 29 at 2:34 AM |
 | Neoleukin Therapeutics, Inc.'s (NLTX) CEO Jonathan Drachman on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 27 at 3:45 AM |
|
| Neoleukin Therapeutics (NASDAQ:NLTX) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS
americanbankingnews.com - March 26 at 11:48 AM |
| Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Receives Consensus Recommendation of "Buy" from Analysts
americanbankingnews.com - March 26 at 2:40 AM |
 | Neoleukin Therapeutics Announces Year End 2020 Financial Results
finance.yahoo.com - March 25 at 8:47 PM |
| Brokerages Anticipate Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) to Announce -$0.21 EPS
americanbankingnews.com - March 20 at 4:10 PM |
| Neoleukin Therapeutics to Host 2020 Financial Results Conference Call and Webcast on March 25, 2021
finance.yahoo.com - March 18 at 12:11 PM |
| Neoleukin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 10:44 AM |
| Neoleukin Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Days
finance.yahoo.com - February 5 at 10:46 AM |
| Neoleukin Therapeutics: De Novo Protein Design Platform
seekingalpha.com - February 5 at 5:46 AM |
| SHAREHOLDER ALERT: Investigation of Neoleukin Therapeutics Announced by Holzer & Holzer, LLC
finance.yahoo.com - January 25 at 5:29 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neoleukin Therapeutics, Inc. - NLTX
finance.yahoo.com - January 24 at 6:18 AM |
| Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Neoleukin Therapeutics, Inc. (NLTX) Investigation
finance.yahoo.com - January 14 at 7:14 PM |
 | Neoleukin Gets FDA Clinical Hold Letter Related To IND Of NL-201 - Quick Facts
nasdaq.com - January 8 at 12:53 PM |
 | Why Neoleukin Therapeutics Stock Is Down Today
fool.com - January 8 at 12:53 PM |
| Neoleukin Therapeutics Receives Clinical Hold Letter from U.S. FDA Related to CMC Assay Development for NL-201
finance.yahoo.com - January 8 at 12:53 PM |
| U.S. FDA puts early-stage trial of Neoleukin potential cancer treatment on hold
finance.yahoo.com - January 8 at 12:53 PM |
| Neoleukin Therapeutics to Present at J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 11:35 AM |
| Neoleukin Therapeutics, Inc.
fool.com - December 24 at 10:36 PM |
| Neoleukin: New Phase 1 Initiation, Strong Managerial Expertise, And Promising Technology
seekingalpha.com - December 18 at 1:28 PM |
| Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer
finance.yahoo.com - December 10 at 9:22 AM |
 | Neoleukin Therapeutics Inc.
barrons.com - November 27 at 12:31 AM |
|
| Neoleukin Therapeutics Announces Participation in Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 23 at 8:21 AM |
 | How One Company Pivoted From Cancer To Coronavirus And Designed A Virus-Blocking Drug In 10 Weeks
forbes.com - November 19 at 1:12 PM |
| Did Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Insiders Buy Up More Shares?
finance.yahoo.com - November 18 at 9:48 AM |
| Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
finance.yahoo.com - November 11 at 12:30 PM |
| Neoleukin Therapeutics Presents Preclinical Combination Data for NL-201 at Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020)
finance.yahoo.com - November 10 at 12:32 PM |
| Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update
finance.yahoo.com - November 9 at 9:53 AM |
| Neoleukin Therapeutics Announces Publication in Science of De Novo Protein Decoys that Block COVID-19 Infection In Vitro and Protect Animals In Vivo
finance.yahoo.com - November 5 at 3:21 PM |
| Neoleukin Therapeutics Appoints Holly K. Vance as General Counsel
finance.yahoo.com - October 20 at 8:21 AM |
| NEOLEUKIN TERAP. -,000001 (6AP.MU)
au.finance.yahoo.com - October 14 at 4:43 AM |
| Neoleukin Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 9 at 8:58 AM |
| What Type Of Shareholders Own The Most Number of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) Shares?
finance.yahoo.com - August 20 at 3:12 PM |
| Neoleukin (NLTX) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - August 19 at 1:14 PM |
| Neoleukin Therapeutics (NLTX) Investor Presentation - Slideshow
seekingalpha.com - August 16 at 4:28 PM |
| Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 11:11 PM |
| Neoleukin Therapeutics Announces Second Quarter 2020 Financial Results & Provides Corporate Update
finance.yahoo.com - August 12 at 6:11 PM |
| Neoleukin Therapeutics to Present at Canaccord Genuity 40th Annual Growth Conference
finance.yahoo.com - August 6 at 9:27 AM |
| Neoleukin Therapeutics to Host Second Quarter 2020 Financial Results & Corporate Update Conference Call and Webcast on August 12, 2020
finance.yahoo.com - August 5 at 12:59 PM |
| Were Hedge Funds Right About Neoleukin Therapeutics, Inc. (NLTX)?
finance.yahoo.com - August 3 at 1:36 PM |
| Is Neoleukin Therapeutics a Buy?
finance.yahoo.com - July 15 at 8:34 AM |
| Neoleukin (NLTX) Moves to Buy: Rationale Behind the Upgrade
finance.yahoo.com - July 3 at 2:27 PM |
